ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Anip Acquisitions D/b/a Ani Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Anip Acquisitions D/b/a Ani Pharmaceuticals, INC. (Ani Pharmaceuticals, INC. 401(k) Plan · EIN 20-0808920 · PN 001): $44.04M net assets, 725 active participants, and $24.59 per $10,000 (24.59 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorAnip Acquisitions D/b/a Ani Pharmaceuticals, INC.
Filing IdentifierAni Pharmaceuticals, INC. 401(k) Plan · EIN 20-0808920 · PN 001
Plan Category & State401(k) Defined Contribution (MN)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$44.04M
Active Participants725
Direct Admin Fee Rate$24.59 per $10,000 (24.59 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderWells Fargo Clearing Services LLC
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($246,497, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI